$CTKB News
Last published 6d ago
- 6d agoCTKBCytek Aurora® Evo System Wins BioTech Breakthrough Award for Drug Discovery Innovation of the YearGlobeNewswireThe Cytek Aurora® Evo system has been named Drug Discovery Innovation of the Year in the 2026 BioTech Breakthrough Awards....
- 6d agoCTKBCytek Aurora® Evo System Wins BioTech Breakthrough Award for Drug Discovery Innovation of the YearGlobeNewswireFREMONT, Calif., Nov. 05, 2026 (GLOBE NEWSWIRE) -- Spectral flow cytometry leader Cytek Biosciences, Inc. (NASDAQ:CTKB) today announced that its Cytek Aurora® Evo system has been named Drug Discovery Innovation of the
- 1w agoCTKBCytek Biosciences, Inc. - EX-99.1Earnings ReleasesForm 8-K - Current report - Item 2.02 Item 9.01
- 1w agoCTKBCytek Biosciences Reports Third Quarter 2026 Financial ResultsGlobeNewswireFREMONT, Calif., Nov. 04, 2026 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. ("Cytek Biosciences" or "Cytek") (NASDAQ:CTKB), a leading cell analysis solutions company, today reported financial results
- 1w agoCTKBThird Quarter 2026 Earnings Conference Call - CYTEK BIOSCIENCES INCEarnings Call TranscriptsHello and thank you for standing by. My name is Lacey and I will be your conference operator today. At this time, I would like to welcome everyone to the SciTech Biosciences third quarter 2026 earnings conference call. A
- 1w agoCTKBCytek Biosciences Third Quarter 2026 Earnings Conference Call - CYTEK BIOSCIENCES INCEarnings Call TranscriptsHello and thank you for standing by. My name is Lacey and I will be your conference operator today. At this time, I would like to welcome everyone to the SciTech Biosciences third quarter 2026 earnings conference call. A
- 1w agoCTKBCytek Biosciences to Participate in Upcoming Investor ConferencesGlobeNewswireFREMONT, Calif., Oct. 29, 2026 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (NASDAQ:CTKB), a leading cell analysis solutions company, today announced the company will be participating in the following investor
- 3w agoCTKBCytek Biosciences to Report Third Quarter 2026 Financial Results on November 4, 2026GlobeNewswireFREMONT, Calif., Oct. 21, 2026 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. ("Cytek Biosciences" or "Cytek") (NASDAQ:CTKB), today announced that it will report financial results for the third quarter of
- 1mo agoCTKBMorgan Stanley 24th Annual Global Healthcare Conference - CYTEK BIOSCIENCES INCEarnings Call TranscriptsWelcome to Day 3 of the Global Healthcare Conference. Really pleased today to be joined by the team from SciTech. We have Wenbin Zhang, CEO, and Bill McComb, CFO. Thank you both for being here. Good morning, Q. And just
- 1mo agoCTKBMorgan Stanley 24th Annual Global Healthcare Conference - CYTEK BIOSCIENCES INCEarnings Call TranscriptsWelcome to Day 3 of the Global Healthcare Conference. Really pleased today to be joined by the team from SciTech. We have Wenbin Zhang, CEO, and Bill McComb, CFO. Thank you both for being here. Good morning, Q. And just
- 2mo agoCTKBSysmex Europe and Cytek® Biosciences Collaborate to Expand Access to Advanced Clinical Flow CytometryGlobeNewswireFREMONT, Calif., and HAMBURG, Germany, Sept. 09, 2026 (GLOBE NEWSWIRE) -- Sysmex Europe SE, a leader in diagnostic and healthcare solutions, and Cytek Biosciences, Inc. (NASDAQ:CTKB), a leader in spectral flow
- 2mo agoCTKBCytek® Biosciences Highlights the Expanding Role of Spectral Flow Cytometry in Clinical Research at ESCCA and ICCSGlobeNewswireFREMONT, Calif., Sept. 03, 2026 (GLOBE NEWSWIRE) -- As clinical laboratories seek deeper cellular insights, greater efficiency, and more streamlined approaches to cell analysis, spectral flow cytometry leader Cytek
- 2mo agoCTKBCytek Biosciences to Participate in Upcoming Investor ConferencesGlobeNewswireFREMONT, Calif., Sept. 01, 2026 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (NASDAQ:CTKB), a leading cell analysis solutions company, today announced the company will be participating in the following investor
- 2mo agoCTKBJury Finds in Cytek’s Favor on Three of Four Asserted Claims; Company to Challenge Remaining FindingGlobeNewswireFREMONT, Calif., Aug. 21, 2026 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. ("Cytek Biosciences," "Cytek," or the "Company") (NASDAQ:CTKB), a leading cell analysis solutions company, today
- 3mo agoCTKBCytek Biosciences Reports Second Quarter 2026 Financial ResultsGlobeNewswireFREMONT, Calif., Aug. 05, 2026 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. ("Cytek Biosciences" or "Cytek") (NASDAQ:CTKB), a leading cell analysis solutions company, today reported financial results
- 3mo agoCTKBCytek Biosciences to Report Second Quarter 2026 Financial Results on August 5, 2026GlobeNewswireFREMONT, Calif., July 22, 2026 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. ("Cytek Biosciences" or "Cytek") (NASDAQ:CTKB), today announced that it will report financial results for the second quarter
- 3mo agoCTKBCytek® Biosciences Opens New Innovation Center in Bellevue to Advance R&D and Customer EngagementGlobeNewswireFREMONT, Calif., July 15, 2026 (GLOBE NEWSWIRE) -- Spectral flow cytometry leader Cytek Biosciences, Inc. (NASDAQ:CTKB) today announced the opening of a new innovation center in Bellevue, Washington, marking the
- 5mo agoCTKBCytek Biosciences to participate at the Singular Research's Las Vegas Invitational ConferenceGlobeNewswireFREMONT, Calif., June 10, 2026 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (NASDAQ:CTKB), a leading cell analysis solutions company, today announced that the company will be participating in the upcoming Singular
- 5mo agoCTKBCytek Biosciences to Unveil Next-Generation Spectral Flow Cytometry Innovations at CYTO 2026GlobeNewswireFREMONT, Calif., June 02, 2026 (GLOBE NEWSWIRE) -- At CYTO 2026, the industry's premier flow cytometry conference, spectral flow cytometry leader Cytek Biosciences, Inc. (NASDAQ:CTKB) will showcase its expanding
- 6mo agoBFLYCTKBHTFLVCYT+1A Toronto AI-Cardiac Diagnostics Company Just Cleared Three of the Hardest Validation Bars in MedtechGlobeNewswireVMS+™ 4.0 system collects a 2026 Edison Award Gold Medal, advances to NMPA regulatory submission in China, and heads to the AEPC pediatric cardiology meeting in Padua, Italy VANCOUVER, British Columbia, May
- 6mo agoCTKBCytek Biosciences First Quarter 2026 Earnings Conference Call - Cytek BiosciencesEarnings Call TranscriptsLadies and gentlemen, thank you for standing by. At this time, I would like to welcome everyone to the SciTech Biosciences First Quarter 2026 Earnings Conference Call. All lines have been placed on mute to prevent any ba
- 6mo agoCTKBCytek Biosciences Reports First Quarter 2026 Financial ResultsGlobeNewswireFREMONT, Calif., May 07, 2026 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. ("Cytek Biosciences" or "Cytek") (NASDAQ:CTKB), a leading cell analysis solutions company, today reported financial results for the first
- 6mo agoCTKBCytek Biosciences to Report First Quarter 2026 Financial Results on May 7, 2026GlobeNewswireFREMONT, Calif., April 23, 2026 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. ("Cytek Biosciences" or "Cytek") (NASDAQ:CTKB), today announced that it will report financial results for the first quarter 2026 after market
- 8mo agoCTKBCytek® Biosciences Celebrates One Year of Operations at Singapore Facility, Accelerating Growth and Regional ImpactGlobeNewswireFREMONT, Calif., March 09, 2026 (GLOBE NEWSWIRE) -- One year after opening its 8,500-square-foot Singapore facility, spectral flow cytometry leader Cytek Biosciences, Inc. (NASDAQ:CTKB) is marking a major milestone in
- 8mo agoCTKBCytek Biosciences Fourth Quarter 2025 Earnings Conference Call - CYTEK BIOSCIENCES INCEarnings Call TranscriptsThank you for standing by. My name is Tina, and I will be your conference operator today. At this time, I would like to welcome everyone to the SciTech Sciences' fourth quarter 2025 earnings call. All lines have been pla
- 8mo agoCTKBCytek Biosciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides 2026 OutlookGlobeNewswireFREMONT, Calif., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Cytek® Biosciences, Inc. ("Cytek Biosciences" or "Cytek") (NASDAQ:CTKB), a leading cell analysis solutions company, today reported financial results for the
- 8mo agoCTKBCytek Biosciences to participate at the TD Cowen 46th Annual Health Care ConferenceGlobeNewswireFREMONT, Calif., Feb. 18, 2026 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (NASDAQ:CTKB), a leading cell analysis solutions company, today announced the company will be participating in the upcoming TD Cowen 46th
- 9mo agoCTKBCytek Biosciences to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026GlobeNewswireFREMONT, Calif., Feb. 12, 2026 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. ("Cytek Biosciences" or "Cytek") (NASDAQ:CTKB), today announced it will report financial results for the fourth quarter and full year 2025
- 10mo agoCTKBCytek Biosciences Announces Preliminary Fourth Quarter and Full Year 2025 Revenue ResultsGlobeNewswireFREMONT, Calif., Jan. 12, 2026 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (NASDAQ:CTKB), a leading cell analysis solutions company, today announced preliminary, unaudited revenue results for the fourth quarter and
- 12mo agoCTKBTIME Recognizes Cytek® Biosciences as One of America's Growth Leaders of 2026GlobeNewswireFREMONT, Calif., Nov. 12, 2025 (GLOBE NEWSWIRE) -- Spectral flow cytometry leader Cytek Biosciences, Inc. (NASDAQ:CTKB) today announced its inclusion on TIME's 2026 list of America's Growth Leaders. Presented in
- 1y agoCTKBCytek® Muse® Micro Cell Analyzer Wins BioTech Breakthrough Award for Drug Discovery Solution of the YearGlobeNewswireFREMONT, Calif., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (NASDAQ:CTKB) announced today that its Cytek® Muse® Micro cell analyzer has been named Drug Discovery Solution of the Year in the
- 1y agoCTKBCytek Biosciences to Participate in Upcoming Investor ConferencesGlobeNewswireFREMONT, Calif., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (NASDAQ:CTKB), a leading cell analysis solutions company, today announced the company will be participating in the following investor
- 1y agoCTKBCytek Biosciences Reports Third Quarter 2025 Financial ResultsGlobeNewswireFREMONT, Calif., Nov. 05, 2025 (GLOBE NEWSWIRE) -- Cytek® Biosciences, Inc. ("Cytek Biosciences" or "Cytek") (NASDAQ:CTKB), a leading cell analysis solutions company, today reported financial results for the third
- 1y agoCTKBCytek® Biosciences Deepens Commitment to Expanding Access to Flow CytometryGlobeNewswireFREMONT, Calif., Oct. 29, 2025 (GLOBE NEWSWIRE) -- Amid the reduction of various government grant programs and global economic challenges that have tightened research funding, Cytek Biosciences, Inc. (NASDAQ:CTKB) is
- 1y agoCTKBCytek Biosciences to Report Third Quarter 2025 Financial Results on November 5, 2025GlobeNewswireFREMONT, Calif., Oct. 22, 2025 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. ("Cytek Biosciences" or "Cytek") (NASDAQ:CTKB), today announced it will report financial results for the third quarter 2025 after market close
- 1y agoCTKBCytek® Biosciences Expands European Presence with New Facility in Amsterdam to Better Serve Customers and Drive GrowthGlobeNewswireFREMONT, Calif., Oct. 15, 2025 (GLOBE NEWSWIRE) -- In a move that strengthens its European operations and enhances service for its customers, spectral flow cytometry leader Cytek Biosciences, Inc. (NASDAQ:CTKB) today
- 1y agoCTKBCytek Biosciences Brings Full Spectrum Cell Analysis to Leading Clinical Global Conferences ICCS and ESCCAGlobeNewswireFREMONT, Calif., Sept. 10, 2025 (GLOBE NEWSWIRE) -- With cancer research and diagnostics driving the need for deeper, faster cellular insights, spectral flow cytometry leader Cytek Biosciences, Inc. (NASDAQ:CTKB) will
- 1y agoCTKBCytek Biosciences, Inc. (CTKB) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript)Earnings Call Transcripts
- 1y agoCTKBCytek Biosciences to Participate in Upcoming Investor ConferencesGlobeNewswireFREMONT, Calif., Aug. 12, 2025 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (NASDAQ:CTKB), a leading cell analysis solutions company, today announced the company will be participating in the following investor
- 1y agoCTKBCytek Biosciences, Inc. (CTKB) Q2 2025 Earnings Call TranscriptEarnings Call Transcripts
- 1y agoCTKBCytek Biosciences Reports Second Quarter 2025 Financial ResultsGlobeNewswireFREMONT, Calif., Aug. 06, 2025 (GLOBE NEWSWIRE) -- Cytek® Biosciences, Inc. ("Cytek Biosciences" or "Cytek") (NASDAQ:CTKB), a leading cell analysis solutions company, today reported financial results for the
- 1y agoCTKBCytek Biosciences to Report Second Quarter 2025 Financial Results on August 6, 2025GlobeNewswireFREMONT, Calif., July 23, 2025 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. ("Cytek Biosciences" or "Cytek") (NASDAQ:CTKB), today announced it will report financial results for the second quarter 2025 after market close
- 1y agoCTKBMDXHMdxhealth Appoints Michael Holder to Board of Directors and Announces Management ChangeGlobeNewswireIRVINE, CA, and HERSTAL, BELGIUM – July 3, 2025 (GlobeNewswire) – MDxHealth SA (NASDAQ:MDXH) (the "Company" or "mdxhealth"), a leading precision diagnostics company, today announced the appointment of
- 1y agoCTKBCytek® Biosciences Is Setting the New Standard for Full Spectrum Flow Cytometry with the New Cytek Aurora™ Evo Flow CytometerGlobeNewswireFREMONT, Calif., May 29, 2025 (GLOBE NEWSWIRE) -- In a move that underscores its dedication to shaping the future of cell analysis, Cytek Biosciences, Inc. (NASDAQ:CTKB) today announced the launch of the Cytek
- 1y agoCTKBCytek Biosciences to participate at the Goldman Sachs 46th Annual Global Healthcare ConferenceGlobeNewswireFREMONT, Calif., May 28, 2025 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (NASDAQ:CTKB), a leading cell analysis solutions company, today announced the company will be participating in the upcoming Goldman Sachs 46th
- 1y agoCTKBCytek Biosciences Reports First Quarter 2025 Financial ResultsGlobeNewswireFREMONT, Calif., May 08, 2025 (GLOBE NEWSWIRE) -- Cytek® Biosciences, Inc. ("Cytek Biosciences" or "Cytek") (NASDAQ:CTKB), a leading cell analysis solutions company, today reported financial results for the first
- 1y agoCTKBCytek® Biosciences Brings Cutting-Edge Cell Analysis Solutions to CYTO and IMMUNOLOGY2025GlobeNewswireFREMONT, Calif., April 29, 2025 (GLOBE NEWSWIRE) -- Continuing its commitment to advancing cell analysis, Cytek Biosciences, Inc. (NASDAQ:CTKB) is showcasing its patented Full Spectrum Profiling™ (FSP®)
- 1y agoCTKBCytek Biosciences to Report First Quarter 2025 Financial Results on May 8, 2025GlobeNewswireFREMONT, Calif., April 24, 2025 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. ("Cytek Biosciences" or "Cytek") (NASDAQ:CTKB), today announced it will report financial results for the first quarter 2025 after market close
- 1y agoCTKBCytek® Biosciences Expands Cell Analysis Offerings with the Affordable, User-Friendly Cytek® Muse® Micro SystemGlobeNewswireFREMONT, Calif., March 18, 2025 (GLOBE NEWSWIRE) -- Today, Cytek Biosciences, Inc. (NASDAQ:CTKB) announced that it has added transformative capabilities to its iconic Cytek® Guava® Muse® cell analyzer,
- 1y agoCTKBCytek Biosciences Reports Fourth Quarter and Full Year 2024 Financial Results and Provides 2025 OutlookGlobeNewswireFREMONT, Calif., Feb. 27, 2025 (GLOBE NEWSWIRE) -- Cytek® Biosciences, Inc. ("Cytek Biosciences" or "Cytek") (NASDAQ:CTKB), a leading cell analysis solutions company, today reported financial results for the